Physician profile
Anthony M Murro
NPI 1740399781
$1,137.84
in general payments reported to CMS, 2019-2025
14 companies · $41.96 in 2025
The $41.96 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $705 · 2020: $277 · 2021: $75.73 · 2022: $16.10 · 2024: $21.95 · 2025: $41.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $63.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $63.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $582.31 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $263.17 | 2019-2021 | |
| Amgen INC. | $46.86 | 2019 | |
| Biogen, INC. | $45.18 | 2021-2025 | Skyclarys |
| Greenwich Biosciences, INC. | $43.00 | 2019-2021 | |
| Abbvie INC. | $38.05 | 2022-2024 | |
| Upsher-Smith Laboratories LLC | $21.60 | 2019 | |
| Amneal Pharmaceuticals LLC | $19.12 | 2025 | Crexont |
| Grifols USA, LLC | $16.07 | 2019 | |
| Eisai INC. | $13.84 | 2019 | |
| Pfizer INC. | $13.52 | 2019 | |
| Acorda Therapeutics, INC | $12.06 | 2020 | |
| Novartis Pharmaceuticals Corporation | $12.01 | 2019 | |
| Natus Medical Incorporated | $11.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Murro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.